• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to "Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis".

作者信息

Patel Jignesh P, Thavarajah Vassan, Roberts Lara N

机构信息

Institute of Pharmaceutical Science, Faculty of Life Sciences and Medicine, King's College London, UK.

King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital Foundation NHS Trust, London, UK.

出版信息

Res Pract Thromb Haemost. 2023 May 9;7(4):100172. doi: 10.1016/j.rpth.2023.100172. eCollection 2023 May.

DOI:10.1016/j.rpth.2023.100172
PMID:37274175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10238255/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23c0/10238255/da4ca6ab3daa/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23c0/10238255/da4ca6ab3daa/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23c0/10238255/da4ca6ab3daa/gr1.jpg

相似文献

1
Response to "Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis".对“肝硬化患者使用治疗剂量直接口服抗凝剂后国际标准化比值和终末期肝病模型评分出现临床相关升高”的回应
Res Pract Thromb Haemost. 2023 May 9;7(4):100172. doi: 10.1016/j.rpth.2023.100172. eCollection 2023 May.
2
Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis.在肝硬化患者中，治疗剂量的直接口服抗凝剂会使国际标准化比值和终末期肝病模型评分出现具有临床意义的升高。
Res Pract Thromb Haemost. 2023 Jan 14;7(1):100052. doi: 10.1016/j.rpth.2023.100052. eCollection 2023 Jan.
3
Rates of Bleeding and Discontinuation of Direct Oral Anticoagulants in Patients With Decompensated Cirrhosis.失代偿期肝硬化患者直接口服抗凝剂出血和停药的发生率。
Clin Gastroenterol Hepatol. 2021 Jul;19(7):1436-1442. doi: 10.1016/j.cgh.2020.08.007. Epub 2020 Aug 8.
4
New predictive model for acute gastrointestinal bleeding in patients taking oral anticoagulants: A cohort study.口服抗凝剂患者急性胃肠道出血的新预测模型：一项队列研究。
J Gastroenterol Hepatol. 2018 Jan;33(1):164-171. doi: 10.1111/jgh.13830.
5
AGA Clinical Practice Update: Coagulation in Cirrhosis.AGA 临床实践更新：肝硬化中的凝血。
Gastroenterology. 2019 Jul;157(1):34-43.e1. doi: 10.1053/j.gastro.2019.03.070. Epub 2019 Apr 12.
6
Assessment of hemostatic profile in patients with mild to advanced liver cirrhosis.评估轻至重度肝硬化患者的止血谱。
World J Gastroenterol. 2020 May 7;26(17):2097-2110. doi: 10.3748/wjg.v26.i17.2097.
7
Management of Coagulation and Anticoagulation in Liver Transplantation Candidates.肝移植候选者的凝血和抗凝管理。
Liver Transpl. 2018 Aug;24(8):1119-1132. doi: 10.1002/lt.25198.
8
[The anaylsis of mortality rate according to CTP score and MELD score in patients with liver cirrhosis].[肝硬化患者基于CTP评分和MELD评分的死亡率分析]
Taehan Kan Hakhoe Chi. 2003 Jun;9(2):98-106.
9
Retrospective Review on the Safety and Efficacy of Direct Oral Anticoagulants Compared With Warfarin in Patients With Cirrhosis.肝硬化患者中直接口服抗凝剂与华法林安全性和有效性的回顾性研究
Fed Pract. 2020 Oct;37(10):479-485. doi: 10.12788/fp.0058.
10
International normalized ratio and Model for End-stage Liver Disease score predict short-term outcome in cirrhotic patients after the resolution of hepatic encephalopathy.国际标准化比值和终末期肝病模型评分可预测肝性脑病缓解后肝硬化患者的短期预后。
World J Gastroenterol. 2019 Jul 14;25(26):3426-3437. doi: 10.3748/wjg.v25.i26.3426.

本文引用的文献

1
Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis.在肝硬化患者中，治疗剂量的直接口服抗凝剂会使国际标准化比值和终末期肝病模型评分出现具有临床意义的升高。
Res Pract Thromb Haemost. 2023 Jan 14;7(1):100052. doi: 10.1016/j.rpth.2023.100052. eCollection 2023 Jan.
2
Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians.直接口服抗凝剂治疗患者的实验室检测：临床医生实用指南。
J Thromb Haemost. 2018 Feb;16(2):209-219. doi: 10.1111/jth.13912. Epub 2017 Dec 28.
3
The International Normalized Ratio calibrated for rivaroxaban has the potential to normalize prothrombin time results for rivaroxaban-treated patients: results of an in vitro study.
利伐沙班校准的国际标准化比值有使利伐沙班治疗患者的凝血酶原时间结果标准化的潜力：一项体外研究的结果
J Thromb Haemost. 2011 Jan;9(1):226-8. doi: 10.1111/j.1538-7836.2010.04106.x.